Cohort
|
HNPCC | 37 | 45.54 (5.71) | |
FAP | 26 | 47.80 (6.20) | |
HBOS | 67 | 42.53 (8.04) | 0.004* |
Age
|
<40 years | 52 | 46.01 (6.47) | |
>40 years | 76 | 43.59 (7.65) | 0.06 |
Gender
|
Female | 105 | 44.14 (7.40) | |
Male | 24 | 46.45 (6.28) | 0.15 |
Disease status
|
Affected | 67 | 43.35 (7.33) | |
Unaffected | 63 | 45.60 (7.27) | 0.08 |
Education
|
>College | 84 | 45.37 (6.43) | |
<College | 45 | 44.14 (7.64) | 0.35 |
Income
|
<$75 000 | 52 | 44.80 (6.75) | |
>$75 000 | 70 | 44.41 (7.76) | 0.77 |
Partner
|
No | 38 | 45.02 (6.71) | |
Yes | 91 | 44.38 (7.48) | 0.64 |
Individuals with children
|
No | 31 | 46.35 (5.05) | |
Yes | 98 | 44.01 (7.74) | 0.11 |
Risk perception of cancer
|
High, very high | 89 | 45.17 (6.70) | |
Average, low, very low | 35 | 44.76 (6.91) | 0.76 |
Perception of test results
|
Have an altered gene | 84 | 44.07 (7.67) | |
Do not have an altered gene | 27 | 46.00 (7.03) | 0.25 |